Compare Stocks: MBOT, MOBI, ELMD, and TLSI

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
ELMD Electromed	$29.60 -1.8%	$41.08	$23.01 ▼ $47.40	$245.09M	0.51	75,228 shs	179,629 shs
MBOT Microbot Medical	$1.48 -1.3%	$1.74	$1.44 ▼ $4.67	$99.40M	1.06	818,678 shs	464,223 shs
MOBI Mobia Medical	$11.34 +7.0%	$12.07	$10.19 ▼ $15.29	$377.52M	N/A	128,154 shs	143,509 shs
TLSI TriSalus Life Sciences	$4.83 -2.0%	$4.66	$2.20 ▼ $7.95	$297.40M	0.43	191,074 shs	79,974 shs

The 7 Hottest IPO Stories of 2026

MarketBeat just released its list of the 7 hottest IPOs expected to hit Wall Street in 2026. See which companies are preparing to go public and why investors are watching closely.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
ELMD Electromed	0.00%	-24.97%	-26.50%	-21.53%	+19.50%
MBOT Microbot Medical	0.00%	-1.33%	-14.94%	-27.09%	-63.64%
MOBI Mobia Medical	0.00%	+6.88%	+1.43%	-13.44%	+1,133,999,900.00%
TLSI TriSalus Life Sciences	0.00%	-8.35%	+5.92%	+41.64%	-5.29%

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
ELMD Electromed	$29.60 -1.8%	$41.08	$23.01 ▼ $47.40	$245.09M	0.51	75,228 shs	179,629 shs
MBOT Microbot Medical	$1.48 -1.3%	$1.74	$1.44 ▼ $4.67	$99.40M	1.06	818,678 shs	464,223 shs
MOBI Mobia Medical	$11.34 +7.0%	$12.07	$10.19 ▼ $15.29	$377.52M	N/A	128,154 shs	143,509 shs
TLSI TriSalus Life Sciences	$4.83 -2.0%	$4.66	$2.20 ▼ $7.95	$297.40M	0.43	191,074 shs	79,974 shs

The 7 Hottest IPO Stories of 2026

MarketBeat just released its list of the 7 hottest IPOs expected to hit Wall Street in 2026. See which companies are preparing to go public and why investors are watching closely.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
ELMD Electromed	0.00%	-24.97%	-26.50%	-21.53%	+19.50%
MBOT Microbot Medical	0.00%	-1.33%	-14.94%	-27.09%	-63.64%
MOBI Mobia Medical	0.00%	+6.88%	+1.43%	-13.44%	+1,133,999,900.00%
TLSI TriSalus Life Sciences	0.00%	-8.35%	+5.92%	+41.64%	-5.29%

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
ELMD Electromed	2.75	Moderate Buy	$43.75	47.80% Upside
MBOT Microbot Medical	2.40	Hold	$6.38	330.74% Upside
MOBI Mobia Medical	2.57	Moderate Buy	$20.75	82.98% Upside
TLSI TriSalus Life Sciences	2.25	Hold	$7.50	55.28% Upside

Current Analyst Ratings Breakdown

Latest MBOT, MOBI, ELMD, and TLSI Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
8/26/2026	ELMD Electromed	Morgan Stanley Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Set Price Target		$50.00
8/26/2026	ELMD Electromed	Lake Street Capital Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Boost Price Target	Buy	$36.00 ➝ $47.00
8/20/2026	MBOT Microbot Medical	Zacks Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Downgrade	Strong-Buy ➝ Hold
8/19/2026	MBOT Microbot Medical	HC Wainwright Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Buy
8/14/2026	MBOT Microbot Medical	B. Riley Financial Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Buy	$5.00 ➝ $4.00
8/12/2026	MOBI Mobia Medical	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Initiated Coverage	Sell (E-)
8/12/2026	MOBI Mobia Medical	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Boost Price Target	Overweight	$15.00 ➝ $17.00
8/12/2026	MOBI Mobia Medical	BTIG Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Buy	$19.00
8/7/2026	TLSI TriSalus Life Sciences	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Sell (E+)
7/22/2026	MBOT Microbot Medical	Zacks Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Upgrade	Hold ➝ Strong-Buy
7/14/2026	MBOT Microbot Medical	HC Wainwright Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Buy

(Data available from 8/30/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
ELMD Electromed	$73.78M	3.32	$0.72 per share	41.36	$5.10 per share	5.80
MBOT Microbot Medical	N/A	N/A	N/A	N/A	$1.03 per share	N/A
MOBI Mobia Medical	$45.28M	8.34	N/A	N/A	$5.18 per share	2.19
TLSI TriSalus Life Sciences	$45.15M	6.59	N/A	N/A	$0.11 per share	43.91

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
ELMD Electromed	$5.15M	$1.31	39.47	N/A	N/A	11.34%	15.71%	13.37%	N/A
MBOT Microbot Medical	-$13.14M	-$0.24	N/A	N/A	N/A	N/A	-21.87%	-20.76%	11/11/2026 (Estimated)
MOBI Mobia Medical	-$46.50M	-$20.18	N/A	N/A	N/A	N/A	N/A	N/A	N/A
TLSI TriSalus Life Sciences	-$39.23M	-$1.30	N/A	N/A	N/A	-62.59%	N/A	-64.47%	11/12/2026 (Estimated)

Latest MBOT, MOBI, ELMD, and TLSI Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
8/11/2026	Q2 2026	MBOT Microbot Medical	-$0.0767	-$0.08	-$0.0033	-$0.08	$0.13 million	$0.24 million
8/11/2026	Q2 2026	MOBI Mobia Medical	-$0.83	-$1.10	-$0.27	-$1.10	N/A	$13.51 million
8/6/2026	Q2 2026	TLSI TriSalus Life Sciences	-$0.1550	-$0.16	-$0.0050	-$0.16	$10.27 million	$11.41 million
6/4/2026	Q1 2026	MOBI Mobia Medical	N/A	-$19.30	N/A	-$19.30	N/A	$12.07 million

Compare Dividends

Company	Annual Payout	Dividend Yield	5-Year Annualized Dividend Growth	Payout Ratio	Years of Consecutive Growth
ELMD Electromed	N/A	N/A	N/A	N/A	N/A
MBOT Microbot Medical	N/A	N/A	N/A	N/A	N/A
MOBI Mobia Medical	N/A	N/A	N/A	N/A	N/A
TLSI TriSalus Life Sciences	N/A	N/A	N/A	N/A	N/A

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
ELMD Electromed	N/A	5.10	4.74
MBOT Microbot Medical	N/A	18.56	17.82
MOBI Mobia Medical	0.04	13.28	12.80
TLSI TriSalus Life Sciences	5.05	5.35	4.97

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
ELMD Electromed	40.82%
MBOT Microbot Medical	16.30%
MOBI Mobia Medical	N/A
TLSI TriSalus Life Sciences	2.58%

Insider Ownership

Company	Insider Ownership
ELMD Electromed	10.50%
MBOT Microbot Medical	4.74%
MOBI Mobia Medical	N/A
TLSI TriSalus Life Sciences	16.30%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
ELMD Electromed	160	8.28 million	7.36 million	Optionable
MBOT Microbot Medical	20	67.17 million	63.98 million	Optionable
MOBI Mobia Medical	N/A	33.29 million	N/A	N/A
TLSI TriSalus Life Sciences	106	61.58 million	51.54 million	Not Optionable

MBOT, MOBI, ELMD, and TLSI Headlines

Recent News About These Companies

Nantahala Capital Management LLC Purchases New Position in TriSalus Life Sciences, Inc. $TLSI

August 29 at 6:39 AM | marketbeat.com

TriSalus Life Sciences (NASDAQ:TLSI) Upgraded at Wall Street Zen

August 23, 2026 | americanbankingnews.com

TriSalus Life Sciences (NASDAQ:TLSI) Upgraded to "Hold" at Wall Street Zen

August 23, 2026 | marketbeat.com

TriSalus Highlights Tumor-Treatment Expansion, FDA Catalyst at Growth Conference

August 17, 2026 | marketbeat.com

TriSalus Life Sciences (NASDAQ:TLSI) Cut to "Sell" at Wall Street Zen

August 15, 2026 | marketbeat.com

TriSalus Life Sciences (NASDAQ:TLSI) Posts Quarterly Earnings Results, Meets Expectations

August 7, 2026 | marketbeat.com

TriSalus Life Sciences Q2 Earnings Call Highlights

August 7, 2026 | marketbeat.com

TriSalus Life Sciences, Inc. (TLSI) Q2 2026 Earnings Call Transcript

August 6, 2026 | seekingalpha.com

TriSalus Life Sciences Reports Second Quarter 2026 Results

August 6, 2026 | businesswire.com

TriSalus Life Sciences to Participate in the Canaccord Genuity 46th Annual Growth Conference

July 29, 2026 | businesswire.com

TriSalus Life Sciences to Host Second Quarter 2026 Financial Results Conference Call

July 16, 2026 | businesswire.com

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of TriSalus Life Sciences Inc. - TLSI

June 25, 2026 | prnewswire.com

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of TriSalus Life Sciences Inc. - TLSI

June 23, 2026 | globenewswire.com

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of TriSalus Life Sciences Inc. - TLSI

June 18, 2026 | prnewswire.com

TLSI Investors Have Opportunity to Join TriSalus Life Sciences, Inc. Fraud Investigation with the Schall Law Firm

June 17, 2026 | globenewswire.com

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of TriSalus Life Sciences Inc. - TLSI

June 16, 2026 | globenewswire.com

TLSI Investors Have Opportunity to Join TriSalus Life Sciences, Inc. Fraud Investigation with the Schall Law Firm

June 11, 2026 | prnewswire.com

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of TriSalus Life Sciences Inc. - TLSI

June 11, 2026 | prnewswire.com

TriSalus Life Sciences to Host Virtual KOL Event on June 24 Featuring New Real-World Evidence for Pressure-Enabled Drug Delivery™ in Liver Cancer

June 10, 2026 | finance.yahoo.com

Why TriSalus Life Sciences, Inc.’s (TLSI) Stock Is Up 5.09%

June 10, 2026 | aaii.comA

TLSI Investors Have Opportunity to Join TriSalus Life Sciences, Inc. Fraud Investigation with the Schall Law Firm

June 10, 2026 | globenewswire.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All

MBOT, MOBI, ELMD, and TLSI Company Descriptions

Electromed NYSE:ELMD

$29.60 -0.54 (-1.79%)

As of 08/28/2026 04:00 PM Eastern

Electromed, Inc. develops, manufactures, markets, and sells airway clearance therapy and related products that apply high frequency chest wall oscillation (HFCWO) therapy in pulmonary care for patients of various ages in the United States and internationally. The company offers SmartVest airway clearance system for patients with compromised pulmonary functions, including bronchiectasis and cystic fibrosis, as well as neuromuscular conditions, such as cerebral palsy and amyotrophic lateral sclerosis; SmartVest SQL System; SmartVest Clearway System that consists of an inflatable therapy garment, a programmable air pulse generator, and a patented single-hose that delivers air pulses from the generator to the garment to create oscillatory pressure on the chest wall; and SmartVest Connect, a wireless technology that allows data connection between physicians and patients to track therapy performance and collaborate in treatment decisions. It also provides single patient use SmartVest and SmartVest Wrap products for health care providers in the acute care setting. The company offers its products to hospitals, home health care centers, pulmonary rehabilitation centers, cystic fibrosis centers, neuromuscular clinics, and other clinics through distributors. It markets its products to physicians, health care providers, and directly to patients. Electromed, Inc. was incorporated in 1992 and is headquartered in New Prague, Minnesota.

Microbot Medical NASDAQ:MBOT

$1.48 -0.02 (-1.33%)

As of 08/28/2026 04:00 PM Eastern

Microbot Medical Inc., a pre-clinical medical device company, engages in the research, design, and development of robotic endoluminal surgery devices targeting the minimally invasive surgery space. The company offers LIBERTY, an endovascular robotic surgical system which allows physicians to conduct a catheter-based procedure from outside the catheterization laboratory, and avoid radiation exposure, physical strain, and the risk of cross contamination for use in cardiovascular, peripheral, and neurovascular spaces. It also provides NovaCross, an intellectual property and technology in the field of intraluminal revascularization devices with anchoring mechanism and integrated microcatheter. The company has a strategic collaboration agreement with Stryker Corporation for technology co-development. Microbot Medical Inc. was founded in 2010 and is based in Braintree, Massachusetts.

Mobia Medical NASDAQ:MOBI

$11.34 +0.74 (+6.98%)

As of 08/28/2026 04:00 PM Eastern

Mobia Medical Inc. is a commercial-stage medical device company redefining stroke recovery for survivors living with life-altering motor impairments. Mobia Medical Inc. is based in AUSTIN, Texas.

TriSalus Life Sciences NASDAQ:TLSI

$4.83 -0.10 (-2.03%)

As of 08/28/2026 04:00 PM Eastern

TriSalus Life Sciences, Inc., a medical technology company, researches, develops, and sells drug delivery technologies and immune-oncology therapeutics for the treatment of liver and pancreatic cancer. The company offers Pressure Enabled Drug Delivery infusion systems, such as the TriNav infusion system, which is used in transarterial radioembolization and chemoembolization procedures for patients with liver cancer and metastases; and the Pancreatic Retrograde Venous Infusion device, which is in Phase 1 clinical trial, for locally advanced pancreatic cancer. It also develops nelitolimod, an investigational immunotherapeutic in Phase 1 clinical trial for the treatment of uveal melanoma with liver metastases, hepatocellular carcinoma, intrahepatic cholangiocarcinoma, and locally advanced pancreatic ductal adenocarcinoma. The company serves interventional radiologists, IR technicians, medical oncologists, nursing support, value analysis committee staff, and patients through its sales representatives and sales managers. TriSalus Life Sciences, Inc. was founded in 2009 and is headquartered in Westminster, Colorado.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time

Compare Price & Volume

Compare Price Performance

Compare Price & Volume

Compare Price Performance

Compare Analyst Forecasts

Current Analyst Ratings Breakdown

Latest MBOT, MOBI, ELMD, and TLSI Analyst Ratings

Compare Sales & Book Value

Compare Profitability & Earnings

Latest MBOT, MOBI, ELMD, and TLSI Earnings

Compare Dividends

Compare Debt

Compare Ownership

Institutional Ownership

Insider Ownership

Compare Miscellaneous Stats

MBOT, MOBI, ELMD, and TLSI Headlines

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

MBOT, MOBI, ELMD, and TLSI Company Descriptions

Electromed NYSE:ELMD

Microbot Medical NASDAQ:MBOT

Mobia Medical NASDAQ:MOBI

TriSalus Life Sciences NASDAQ:TLSI

More Stock Comparisions from MarketBeat

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

More Stock Ideas from MarketBeat

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Compare Stocks

Comparative Price Performance Over Time

Compare Price & Volume

Compare Price Performance

Compare Price & Volume

Compare Price Performance

Compare Analyst Forecasts

Current Analyst Ratings Breakdown

Latest MBOT, MOBI, ELMD, and TLSI Analyst Ratings

Compare Sales & Book Value

Compare Profitability & Earnings

Latest MBOT, MOBI, ELMD, and TLSI Earnings

Compare Dividends

Compare Debt

Compare Ownership

Institutional Ownership

Insider Ownership

Compare Miscellaneous Stats

MBOT, MOBI, ELMD, and TLSI Headlines

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

MBOT, MOBI, ELMD, and TLSI Company Descriptions

Electromed NYSE:ELMD

Microbot Medical NASDAQ:MBOT

Mobia Medical NASDAQ:MOBI

TriSalus Life Sciences NASDAQ:TLSI

More Stock Comparisions from MarketBeat

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

More Stock Ideas from MarketBeat

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools